# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA615179 | Functional | Cytotoxicity against ovarian cancer cell line (1A-9) of humans was determined | Homo sapiens | 4 | ALA1135863 | cell-based format | Scientific Literature | |
2. | ALA615183 | Functional | In vitro effective concentration required to reduce the number of human ovarian cancer (1A9) after 3-day incubation | Homo sapiens | 10 | ALA1134259 | cell-based format | Scientific Literature | |
3. | ALA615184 | Functional | In vitro effective concentration required to reduce the number of human ovarian cancer cells (1A9) after 3-day incubation | Homo sapiens | 1 | ALA1134259 | cell-based format | Scientific Literature | |
4. | ALA615185 | Functional | Cytotoxic activity against human ovarian cancer (1A9) cell line | Homo sapiens | 4 | ALA1132059 | cell-based format | Scientific Literature | |
5. | ALA615186 | Functional | Cytotoxic activity against human ovarian cancer (1A9) cell line; ND=Not determined | Homo sapiens | 4 | ALA1132059 | cell-based format | Scientific Literature | |
6. | ALA615187 | Functional | Effective dose of compound against replication of 1A9 cell line was evaluated | Homo sapiens | 2 | ALA1147640 | cell-based format | Scientific Literature | |
7. | ALA885343 | Functional | In vitro cytotoxic activity was determined against ovarian cancer (1A9) cell line | Homo sapiens | 26 | ALA1131893 | cell-based format | Scientific Literature | |
8. | ALA615188 | Functional | In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line) | Homo sapiens | 6 | ALA1136183 | cell-based format | Scientific Literature | |
9. | ALA615189 | Functional | In vitro cytotoxicity evaluated against human ovarian cancer (1A9 cell line); NA is not active | Homo sapiens | 1 | ALA1136183 | cell-based format | Scientific Literature | |
10. | ALA615190 | Functional | In vitro percent inhibition evaluated against human ovarian cancer (1A9 cell line) at >20 ug/mL | Homo sapiens | 3 | ALA1136183 | cell-based format | Scientific Literature | |
11. | ALA615191 | Functional | Inhibitory activity against Taxol resistant 1A9 cell lines | Homo sapiens | 6 | ALA1132033 | cell-based format | Scientific Literature | |
12. | ALA615192 | Functional | Cytotoxicity against human ovarian cancer (1A9) cell lines. | Homo sapiens | 6 | ALA1131861 | cell-based format | Scientific Literature | |
13. | ALA827083 | Functional | Percentage inhibition of human ovarian cancer (1A9) cell lines. | Homo sapiens | 1 | ALA1131861 | cell-based format | Scientific Literature | |
14. | ALA615193 | Functional | Effective dose required for inhibitory activity against 1A9 human tumor cell line. | Homo sapiens | 26 | ALA1145845 | cell-based format | Scientific Literature | |
15. | ALA615194 | Functional | Percent inhibition against 1A9 human tumor cell line at 0.10 ug/mL | Homo sapiens | 1 | ALA1145845 | cell-based format | Scientific Literature | |
16. | ALA615195 | Functional | Percent inhibition against 1A9 human tumor cell line at <0.00008 ug/mL | Homo sapiens | 1 | ALA1145845 | cell-based format | Scientific Literature | |
17. | ALA615196 | Functional | Percent inhibition against 1A9 human tumor cell line at >10 ug/mL | Homo sapiens | 1 | ALA1145845 | cell-based format | Scientific Literature | |
18. | ALA702059 | Functional | In vitro cytotoxicity against human ovarian cancer (IA9) cell line | Homo sapiens | 9 | ALA1133323 | cell-based format | Scientific Literature | |
19. | ALA702060 | Functional | Tested in vitro for cytotoxic activity against Human ovarian cancer (IA9) cell line | Homo sapiens | 22 | ALA1133524 | cell-based format | Scientific Literature | |
20. | ALA702061 | Functional | Tested in vitro for cytotoxic activity against Human ovarian cancer (IA9) cell line; NA means Not active | Homo sapiens | 4 | ALA1133524 | cell-based format | Scientific Literature |